Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Biliary Tract Diseases

  Free Subscription

Articles published in Cancer

Retrieve available abstracts of 18 articles:
HTML format
Text format

Single Articles

    December 2017
  1. MOMENI-BOROUJENI A, Yousefi E, Somma J
    Computer-assisted cytologic diagnosis in pancreatic FNA: An application of neural networks to image analysis.
    Cancer. 2017;125:926-933.
    PubMed     Text format     Abstract available

    August 2017
  2. TRAN CAO HS, Zhang Q, Sada YH, Chai C, et al
    The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts.
    Cancer. 2017 Aug 25. doi: 10.1002/cncr.30968.
    PubMed     Text format     Abstract available

    July 2017
  3. LEWIS DR, Chen HS, Cockburn MG, Wu XC, et al
    Early estimates of SEER cancer incidence, 2014.
    Cancer. 2017;123:2524-2534.
    PubMed     Text format     Abstract available

    June 2017
  4. WALTERHOUSE DO, Pappo AS, Meza JL, Breneman JC, et al
    Reduction of cyclophosphamide dose for patients with subset 2 low-risk rhabdomyosarcoma is associated with an increased risk of recurrence: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
    Cancer. 2017;123:2368-2375.
    PubMed     Text format     Abstract available

    May 2017
  5. GULHATI P, Raghav K, Shroff RT, Varadhachary GR, et al
    Bevacizumab combined with capecitabine and oxaliplatin in patients with advanced adenocarcinoma of the small bowel or ampulla of vater: A single-center, open-label, phase 2 study.
    Cancer. 2017;123:1011-1017.
    PubMed     Text format     Abstract available

  6. ROSENBAUM MW, Cauley CE, Kulemann B, Liss AS, et al
    Cytologic characteristics of circulating epithelioid cells in pancreatic disease.
    Cancer. 2017;125:332-340.
    PubMed     Text format     Abstract available

    February 2017
  7. GOYAL L, Zheng H, Yurgelun MB, Abrams TA, et al
    A phase 2 and biomarker study of cabozantinib in patients with advanced cholangiocarcinoma.
    Cancer. 2017 Feb 13. doi: 10.1002/cncr.30571.
    PubMed     Text format     Abstract available

    December 2016
  8. YAMASHITA S, Koay EJ, Passot G, Shroff R, et al
    Local therapy reduces the risk of liver failure and improves survival in patients with intrahepatic cholangiocarcinoma: A comprehensive analysis of 362 consecutive patients.
    Cancer. 2016 Dec 16. doi: 10.1002/cncr.30488.
    PubMed     Text format     Abstract available

    October 2016
    Cancer Cytopathology: 20 years of advancing the field of pancreaticobiliary cytopathology.
    Cancer. 2016;124:690-694.
    PubMed     Text format    

    September 2016
  10. JAVLE M, Bekaii-Saab T, Jain A, Wang Y, et al
    Biliary cancer: Utility of next-generation sequencing for clinical management.
    Cancer. 2016 Sep 13. doi: 10.1002/cncr.30254.
    PubMed     Text format     Abstract available

    August 2016
  11. AHN DH, Javle M, Ahn CW, Jain A, et al
    Next-generation sequencing survey of biliary tract cancer reveals the association between tumor somatic variants and chemotherapy resistance.
    Cancer. 2016 Aug 6. doi: 10.1002/cncr.30247.
    PubMed     Text format     Abstract available

    May 2016
  12. FLEMMING JA, Zhang-Salomons J, Nanji S, Booth CM, et al
    Increased incidence but improved median overall survival for biliary tract cancers diagnosed in Ontario from 1994 through 2012: A population-based study.
    Cancer. 2016 May 16. doi: 10.1002/cncr.30074.
    PubMed     Text format     Abstract available

    January 2016
  13. ESNAOLA NF, Meyer JE, Karachristos A, Maranki JL, et al
    Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma.
    Cancer. 2016 Jan 22. doi: 10.1002/cncr.29692.
    PubMed     Text format     Abstract available

    December 2015
  14. KONSTANTINIDIS IT, Koerkamp BG, Do RK, Gonen M, et al
    Unresectable intrahepatic cholangiocarcinoma: Systemic plus hepatic arterial infusion chemotherapy is associated with longer survival in comparison with systemic chemotherapy alone.
    Cancer. 2015 Dec 22. doi: 10.1002/cncr.29824.
    PubMed     Text format     Abstract available

    November 2015
  15. LEONE F, Marino D, Cereda S, Filippi R, et al
    Panitumumab in combination with gemcitabine and oxaliplatin does not prolong survival in wild-type KRAS advanced biliary tract cancer: A randomized phase 2 trial (Vecti-BIL study).
    Cancer. 2015 Nov 5. doi: 10.1002/cncr.29778.
    PubMed     Text format     Abstract available

    October 2015
  16. SAKAMOTO Y, Kokudo N, Matsuyama Y, Sakamoto M, et al
    Proposal of a new staging system for intrahepatic cholangiocarcinoma: Analysis of surgical patients from a nationwide survey of the Liver Cancer Study Group of Japan.
    Cancer. 2015 Oct 2. doi: 10.1002/cncr.29686.
    PubMed     Text format     Abstract available

    August 2015
  17. SPOLVERATO G, Vitale A, Cucchetti A, Popescu I, et al
    Can hepatic resection provide a long-term cure for patients with intrahepatic cholangiocarcinoma?
    Cancer. 2015 Aug 11. doi: 10.1002/cncr.29619.
    PubMed     Text format     Abstract available

    June 2015
  18. BRIEAU B, Dahan L, De Rycke Y, Boussaha T, et al
    Second-line chemotherapy for advanced biliary tract cancer after failure of the gemcitabine-platinum combination: A large multicenter study by the Association des Gastro-Enterologues Oncologues.
    Cancer. 2015 Jun 5. doi: 10.1002/cncr.29471.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Biliary Tract Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.